H. Spiridonidis
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
Papers in
-
- Lung Cancer Treatments and Mutations 5
- Prostate Cancer Treatment and Research 1
- Oncology 5
- Neutropenia and Cancer Infections 2
- Cancer Treatment and Pharmacology 2
- Colorectal Cancer Treatments and Studies 2
- HER2/EGFR in Cancer Research 1
- Lung Cancer Research Studies 1
- Co-authors
- Mark G. Kris (2 shared papers)David Cella (3 shared papers)Ronald B. Natale (2 shared papers)Andrea Kay (2 shared papers)Chandra P. Belani (2 shared papers)Judith Ochs (2 shared papers)Roy S. Herbst (2 shared papers)Diane Prager (3 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)JAMA (1 paper)Asia-Pacific Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesSingaporeBrazil
In The Last Decade
H. Spiridonidis
8 papers receiving 2.1k citations
H. Spiridonidis's Hit Papers
Peers
Comparison fields: 5 of 69
- Pulmonary and Respiratory Medicine 1.5k
- Oncology 1.2k
- Cancer Research 225
- Molecular Biology 429
- Genetics 57
Countries citing papers authored by H. Spiridonidis
This map shows the geographic impact of H. Spiridonidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Spiridonidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Spiridonidis more than expected).
Fields of papers citing papers by H. Spiridonidis
This network shows the impact of papers produced by H. Spiridonidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Spiridonidis. The network helps show where H. Spiridonidis may publish in the future.
Co-authors
The 25 scholars most cited alongside H. Spiridonidis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer Hit paper breakdown → | 2003 | 2121 |
| 2 | Efficacy and safety of gefitinib (Iressa, ZD1839), an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with advanced non-small cell lung cancer | 2003 | 11 |
| 3 | 2010 | 4 | |
| 4 | 2004 | 3 | |
| 5 | Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non-Small Cell Lung Cancer | 2017 | 3 |
| 6 | 2004 | 2 | |
| 7 | 2004 | 1 | |
| 8 | 2004 | 1 |
About H. Spiridonidis
H. Spiridonidis is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Organic Chemistry, Genetics and Cancer Research, having authored 8 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Neutropenia and Cancer Infections (2 papers), Cancer Treatment and Pharmacology (2 papers), Colorectal Cancer Treatments and Studies (2 papers), HER2/EGFR in Cancer Research (1 paper), Prostate Cancer Treatment and Research (1 paper), Cancer Genomics and Diagnostics (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.5k citations), Oncology (1.2k citations), Cancer Research (225 citations), Molecular Biology (429 citations) and Genetics (57 citations). H. Spiridonidis has collaborated with scholars based in United States, Singapore and Brazil. Frequent co-authors include Mark G. Kris, David Cella, Ronald B. Natale, Andrea Kay, Chandra P. Belani, Judith Ochs, Roy S. Herbst, Diane Prager, Steven D. Averbuch and Michael Wolf. Their work appears in journals such as Journal of Clinical Oncology, JAMA and Asia-Pacific Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.